Skip to main content
ZheJiang Tailin Bioengineering Co.,Ltd logo

ZheJiang Tailin Bioengineering Co.,Ltd — Investor Relations & Filings

Ticker · 300813 ISIN · CNE100003S89 Shenzhen Stock Exchange Manufacturing
Open in API
Filings indexed 1,000 across all filing types
Latest filing 2022-05-09 Share Issue/Capital Cha…
Country CN China
Listing Shenzhen Stock Exchange 300813

About ZheJiang Tailin Bioengineering Co.,Ltd

https://www.tailingood.com

ZheJiang Tailin Bioengineering Co.,Ltd. specializes in the research, development, and manufacturing of high-tech equipment for life sciences and pharmaceutical engineering. The company provides integrated solutions for microbial control, sterility testing, and aseptic processing. Its core product portfolio includes sterility test canisters and pumps, microbial limit testing systems, and hydrogen peroxide vapor (VHP) decontamination units. Tailin also develops advanced isolator technology for containment and aseptic applications, alongside analytical instruments such as Total Organic Carbon (TOC) analyzers and filter integrity testers. These products are designed to meet international regulatory standards, including GMP, USP, and EP. The company serves sectors such as biopharmaceuticals, medical devices, and laboratory research, focusing on product safety and quality through specialized engineering and microbial detection technologies.

Recent filings

Filing Released Lang Actions
关于向激励对象首次授予限制性股票的公告
Share Issue/Capital Change Classification · 95% confidence The document is a detailed announcement regarding the initial grant of restricted stock under a 2022 restricted stock incentive plan by Zhejiang Tailin Biotechnology Co., Ltd. It includes specifics such as grant date, number of shares, grant price, allocation among recipients, approval procedures, performance conditions, accounting treatment, and legal and financial advisor opinions. The content focuses on the company's stock incentive plan and the granting of shares to management and employees. This is not a full annual or interim financial report, nor is it a simple announcement of a report. It is also not a regulatory filing or certification. The document is a formal announcement of a capital change related to share issuance under an equity incentive plan. Therefore, the most appropriate classification is Share Issue/Capital Change (SHA). The document length and detail confirm it is not a brief announcement but a substantive disclosure about capital changes.
2022-05-09 Chinese
关于全资子公司变更注册资本并完成工商变更登记的公告
Share Issue/Capital Change Classification · 95% confidence The document is a company announcement regarding a capital increase in a wholly-owned subsidiary and the completion of related business registration changes. It details the change in registered capital and provides updated business license information. The document is short (1165 characters) and focuses on a capital change event rather than financial results or detailed financial data. It does not contain financial statements or management discussion. Therefore, it fits the category of a Share Issue/Capital Change announcement rather than a full financial report or other categories.
2022-05-06 Chinese
关于2022年限制性股票激励计划内幕信息知情人买卖公司股票情况的自查报告
Regulatory Filings Classification · 95% confidence The document is a self-inspection report regarding insider trading activities related to a 2022 restricted stock incentive plan. It details the investigation of stock transactions by insiders during a specific period and concludes no insider trading occurred. The document references regulatory compliance and internal controls but does not contain financial statements or earnings data. It is a regulatory announcement about insider trading compliance rather than a financial report or management update. Therefore, it fits best under Regulatory Filings (RNS). The document length is short and it is an announcement/report on compliance rather than a full report or audit.
2022-04-29 Chinese
监事会关于2022年限制性股票激励计划激励对象名单的审核意见及公示情况说明
Regulatory Filings Classification · 95% confidence The document is a formal announcement from the supervisory board regarding the review and public disclosure of the list of incentive recipients under the company's 2022 restricted stock incentive plan. It includes details about the internal verification process, compliance with relevant laws and regulations, and confirmation that the incentive recipients meet the required qualifications. The document does not contain financial statements or detailed financial performance data, nor is it a report of voting results or a management change announcement. It is a regulatory disclosure related to stock incentive plans and compliance, which fits best under Regulatory Filings (RNS) as it does not match other more specific categories like Remuneration Information or Share Issue/Capital Change. The document length is short and it is an announcement rather than a full report.
2022-04-29 Chinese
关于2022年第一季度报告披露的提示性公告
Report Publication Announcement Classification · 100% confidence The document is very short (326 characters) and is an announcement stating that the company's 2022 first quarter report has been disclosed on a regulatory website. It does not contain the actual financial data or report itself, but rather directs investors to where the report can be found. This fits the pattern of a Report Publication Announcement (RPA) rather than the report itself (such as an Interim/Quarterly Report).
2022-04-28 Chinese
第三届监事会第六次会议决议公告
Regulatory Filings Classification · 95% confidence The document is an announcement of the Supervisory Board meeting resolution approving the company's 2022 first quarter report. It states that the full quarterly report is published on an external website and does not contain the actual financial data or detailed report content itself. The document is short (730 characters) and serves to disclose the meeting decision and direct readers to the full report elsewhere. Therefore, it is not the quarterly report itself but an announcement related to it. According to the rules, such announcements are classified as Regulatory Filings (RNS) because they do not contain substantive financial data but are official disclosures related to regulatory compliance.
2022-04-28 Chinese

Browse filings by year

8 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.